References 1. Boolchand V, Olds G, Singh J, Singh P, Chak A, Cooper G (2006) Colorectal screening after polypectomy: a national survey study of primary care physicians. Ann Intern Med 145: 654–659. 2. Damle R, Temburni S, Calissano C, Yancopoulos S, Banapour T, et al. (2007) CD38 labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood Epub Ahead of Print. 3. Mandel M, Achiron A (2006) Gene expression studies in systemic lupus erythematosus. Lupus 15: 451–456. 4. Heller R, Schena M, Chai A, Shalon D, Bedilion T, et al. (1997) Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA. pp 2150–2155. 5. Edwards C, Feldman J, Beech J, Shields K, Stover J, et al. (2007) Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis. Mol Med 13: 40–58. 6. Baird A (2007) Blood genomics in human stroke. Stroke 38: 694–698. 7. Rubins K, Hensley L, Jahrling P, Whitney A, Geisbert T, et al. (2004) The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a non-human primate model. Proc Natl Acad Sci USA 101: 15190–15195. 8. Martin K, Graner E, Li Y, Price L, Kritzman B, et al. (2001) High sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood. Proc Natl Acad Sci USA 98: 2646–2651. 9. Patino W, Mian O, Kang J, Matoba S, Bartlett L, et al. (2005) Circulating transcriptome reveals markers of atherosclerosis. Proc Natl Acad Sci USA 102: 3423–3428. 10. Lampe J, Strepaniants S, Mao M, Radich J, Dai H, et al. (2004) Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. Cancer Epidemiol Biomarkers Prev 13: 445–453. 11. Ramilo O, Allman W, Chung W, Mejias A, Ardura M, et al. (2007) Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109: 2066–2077. 12. Whitney A, Diehn M, Popper S, Alizadeh A, Boldrick J, et al. (2003) Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 101: 1896–1901. 13. Yan H, Yuan W, Velculescu V, Vogelstein B, Kinzler K (2002) Allelic variation in human gene expression. Science 297: 1143. 14. Kaiser J (2003) Hormesis: a healthful dab of radiation. Science 302: 378. 15. Wasalenko J, MacVittie T, Blakely W, Pesik N, Wiley A, et al. (2004) Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Int Med 140: 1037–51. 16. Mettler F, Voelz G (2002) Major radiation exposure: what to expect and how to respond. N Engl J Med 346: 1554–61. 17. Dainiak N (2002) Hematologic consequences of exposure to ionizing radiation. Exp Hematol 30: 513–28. 18. Iwamoto K, Mizuno T, Tokuoka S, Mabuchi K, Seyama T (1998) Frequency of p53 mutations in hepatocellular carcinomas from atomic bomb survivors. J Natl Canc Inst 90: 1167–1168. 19. Hirai Y, Kusonoki Y, Kyoizumi S, Awa A, Pawel D, et al. (1995) Mutant frequency at the HPRT locus in peripheral blood T-lymphocytes of atomic bomb survivors. Mutant Res 329: 183–196. 20. Takeshima Y, Seyama T, Bennet W, Akiyama M, Tokuoka S, et al. p53 mutations in lung cancers from non-smoking atomic bomb survivors. Lancet 342: 1520–1521. 21. Neel J, Lewis S (1990) The comparative radiation genetics of humans and mice. Annu Rev Genet 24: 327–362. 22. Jen K, Cheung V (2003) Transcriptional response of lymphoblastoid cells to ionizing radiation. Genome Res 13: 2092–2100. 23. Amundson S, Do K, Shahab S, Bittner M, Meltzer P, et al. (2000) Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiat Res 154: 342–346. Radiation Signatures 24. Amundson S, Bittner M, Meltzer P, Trent J, Fornace A (2001) Induction of gene expression as a monitor of exposure to radiation exposure. Radiat Res 156: 657–661. 25. Falt S, Holmberg K, Lambert B, Wennborg A (2003) Long-term global gene expression patterns in irradiated human lymphocytes. Carcinogenesis 24: 1837–1845. 26. Amundson S, Grace M, McLeland C, Epperly M, Yeager A, et al. (2004) Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients. Cancer Res 64: 6368–6371. 27. Dressman H, Muramoto G, Chao N, Meadows S, Marshall D, Ginsburg G, Nevins J, Chute J (2007) Gene expression signatures that predict radiation exposure in mice and humans. PLoS Med 4: 690–701. 28. Hick R, Gruver A, Ventevogel M, Haynes B, Sempowski G (2006) Leptin selectively augments thymopoiesis in leptin deficiency and lipopolysaccharide induced thymic atrophy. J Immunol 177: 169–176. 29. Pournara I, Wernisch L (2007) Factor analysis for gene regulatory networks and transcription factor activity profiles. BMC Bioinformatics 23: 1–20. 30. Hsieh S, Lo P, Wang F (2002) Mouse DDA3 gene is a direct transcriptional target of p53 and p73. Oncogene 21: 3050–3057. 31. Valenzuela H, Pace K, Cabrera P, White R, Porvari K, et al. (2007) O- glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin 1. Cancer Res 67: 6155–6162. 32. Inoue K, Takano H, Shimada A, Wada E, Yanagisawa R, Sakurai M, Satoh M, Yoshikawa T (2006) Role of matallothionein in coagulatory disturbance and systemic inflammation induced by lipopolysaccharide in mice. FASEB J 20: 533–535. 33. Potti A, Mukherjee S, Peterson R, Dressman H, Bild A, et al. (2006) A genomic strategy to refine prognosis in early stage non-small cell lung cancer. N Engl J Med 355: 570–580. 34. Cheng S, Horng C, West M, Huang E, Pittman J, et al. (2006) Genomic prediction of locoregional recurrence after mastectomy in breast cancer. J Clin Oncol 24: 4594–4602. 35. Potti A, Dressman H, Bild A, Reidel R, Chan G, et al. (2006) Genomic signatures to guide the use of chemotherapeutics. Nat Med 12: 1294–1300. 36. Nevins JR, Potti A (2007) Mining gene expression profiles: expression signatures as cancer phenotypes. Nat Rev Genet 8: 601–609. 37. Alizadeh A, Eisen M, Davis R, Ma C, Lossos I, et al. (2000) Distinct types of diffuse large B cell lymphoma identified by gene expression profiling. Nature 403: 503–511. 38. Horwitz P, Tsai E, Putt M, Gilmore J, Lepore J, Parmacek M, Kao A, Desai S, Goldberg L, Brozena S, et al. (2004) Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 110: 3815–3821. 39. Lin B, Vahey M, Thach D, Stenger D, Pancrazio J (2003) Biological threat detection via host gene expression profiling. Clinic Chem 49: 1045–1049. 40. Boldrick J, Alizadeh A, Diehn M, Dudoit S, Liu C, et al. (2002) Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc Natl Acad Sci USA 99: 972–977. 41. Seierstad T, Stranden E, Bjering K, Evensen M, Holt A, et al. (2007) Doses to nuclear technicians in a dedicated PET/CT centre uitlising 18F fluorodeox- yglucose (FDG). Radiat Prot Dosimetry 123: 246–249. 42. Moore D, Tucker J, Jones I, Langlois R, Pleshanov P, et al. (1997) A study of the effects of exposure on cleanup workers at the Chernobyl nuclear reactor accident using multiple endpoints. Radiat Res 148: 463–475. 43. Einstein A, Moser K, Thompson R, Cerqueira M, Henzlova M (2007) Radiation dose to patients from cardiac diagnostic imaging. Circulation 116: 1290–1305. PLoS ONE | www.plosone.org 9 April 2008 | Volume 3 | Issue 4 | e1912